-
1.发明授权Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them 有权杂芳基取代的1,3-二氢吲哚-2-酮衍生物和含有它们的药物公开(公告)号：US09487505B2
公开(公告)日：2016-11-08
申请号：US14037026
申请日：2013-09-25
发明人： Wilfried Lubisch , Wilfried Hornberger , Thorsten K. Oost , Daryl Richard Sauer , Liliane Unger , Wolfgang Wernet , Hervé Geneste
IPC分类号： A01N43/38 , C07D403/14 , C07D401/04 , C07D403/04 , C07D403/12 , C07D405/14 , C07D409/04 , C07D401/14 , C07D413/14 , C07D417/14
CPC分类号： C07D403/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6 and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
-
2.发明申请HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM 审中-公开异取代的1,3-二氢吲哚-2-酮衍生物和含有它们的药物公开(公告)号：US20170050959A1
公开(公告)日：2017-02-23
申请号：US15345204
申请日：2016-11-07
发明人： Wilfried Lubisch , Wilfried Hornberger , Thorsten K. Oost , Daryl Richard Sauer , Liliane Unger , Wolfgang Wernet , Hervé Geneste
IPC分类号： C07D417/14 , C07D403/14 , C07D401/04 , C07D413/14 , C07D409/04 , C07D401/14 , C07D405/14
CPC分类号： C07D417/14 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D513/04
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in whichA, R3, R4, R5, R6 and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivaties can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
摘要翻译： A，R3，R4，R5，R6和R7如权利要求1所定义，以及含有它们用于治疗疾病的药物。 特别地，新羟吲哚衍生物可用于控制和/或预防各种加压素依赖性或催产素依赖性疾病。
-
3.发明授权Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them 有权杂芳基取代的1,3-二氢吲哚-2-酮衍生物和含有它们的药物公开(公告)号：US08580842B2
公开(公告)日：2013-11-12
申请号：US12839595
申请日：2010-07-20
申请人： Wilfried Lubisch , Wilfried Hornberger , Thorsten Oost , Daryl Richard Sauer , Liliane Unger , Hervé Geneste , Andrea Hager-Wernet
发明人： Wilfried Lubisch , Wilfried Hornberger , Thorsten Oost , Daryl Richard Sauer , Liliane Unger , Wolfgang Wernet , Hervé Geneste
IPC分类号： A01N43/38 , C07D411/00
CPC分类号： C07D403/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6, and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
摘要翻译： 本发明涉及式（I）的新的1,3-二氢吲哚-2-酮（羟吲哚）衍生物，其中A，R3，R4，R5，R6和R7如权利要求1所定义， 他们为治疗疾病。 特别地，新型羟基吲哚衍生物可用于控制和/或预防各种加压素依赖性或催产素依赖性疾病。
-
4.发明授权公开(公告)号：US08350055B2
公开(公告)日：2013-01-08
申请号：US12839612
申请日：2010-07-20
申请人： Thorsten Oost , Wilfried Hornberger , Herve Geneste , Daryl Richard Sauer , Wolfgang Wernet , Andrea Hager-Wernet, legal representative , Liliane Unger , Wilfried Lubisch
发明人： Thorsten Oost , Wilfried Hornberger , Herve Geneste , Daryl Richard Sauer , Wolfgang Wernet , Liliane Unger , Wilfried Lubisch
IPC分类号： C07D411/00
CPC分类号： C07D401/14 , C07D401/12 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14 , C07D513/04
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6, and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
-
5.发明申请HETEROARYL-SUBSTITUTED 1,3-DIHYDROINDOL-2-ONE DERIVATIVES AND MEDICAMENTS CONTAINING THEM 有权异取代的1,3-二氢吲哚-2-酮衍生物和含有它们的药物公开(公告)号：US20110077241A1
公开(公告)日：2011-03-31
申请号：US12839595
申请日：2010-07-20
申请人： Wilfried Lubisch , Wilfried Hornberger , Thorsten Oost , Daryl Richard Sauer , Liliane Unger , Wolfgang Wernet , Hervé Geneste , Andrea Hager-Wernet
发明人： Wilfried Lubisch , Wilfried Hornberger , Thorsten Oost , Daryl Richard Sauer , Liliane Unger , Wolfgang Wernet , Hervé Geneste , Andrea Hager-Wernet
IPC分类号： A61K31/538 , C07D417/14 , A61K31/428 , C07D403/14 , A61K31/506 , C07D401/14 , A61K31/4439 , A61K31/497 , A61K31/501 , A61K31/4725 , A61K31/4709 , C07D409/14 , A61K31/404 , C07D413/14 , A61K31/5377 , A61K31/496 , A61P25/28 , A61P5/46 , A61P25/24 , A61P25/18 , A61P25/00
CPC分类号： C07D403/14 , C07D401/04 , C07D401/14 , C07D403/04 , C07D403/12 , C07D405/14 , C07D409/04 , C07D413/14 , C07D417/14
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6, and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
摘要翻译： 本发明涉及式（I）的新的1,3-二氢吲哚-2-酮（羟吲哚）衍生物，其中A，R3，R4，R5，R6和R7如权利要求1所定义， 他们为治疗疾病。 特别地，新型羟基吲哚衍生物可用于控制和/或预防各种加压素依赖性或催产素依赖性疾病。
-
6.发明申请公开(公告)号：US20110071156A1
公开(公告)日：2011-03-24
申请号：US12839612
申请日：2010-07-20
申请人： Thorsten Oost , Wilfried Hornberger , Herve Geneste , Daryl Richard Sauer , Wolfgang Wernet , Andrea Hager-Wernet , Liliane Unger , Wilfried Lubisch
发明人： Thorsten Oost , Wilfried Hornberger , Herve Geneste , Daryl Richard Sauer , Wolfgang Wernet , Andrea Hager-Wernet , Liliane Unger , Wilfried Lubisch
IPC分类号： A61K31/501 , C07D417/14 , A61K31/428 , C07D403/14 , A61K31/513 , C07D401/14 , A61K31/4439 , A61K31/497 , A61K31/4725 , A61K31/4709 , A61K31/4184 , A61K31/405 , A61K31/496 , A61P25/00
CPC分类号： C07D401/14 , C07D401/12 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D413/14 , C07D417/14 , C07D513/04
摘要： The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6, and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.023 秒)
